SCHEMBL29635644

SCHEMBL29635644

c1cc2c3c(cccc3c1)NCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
CYP3A4 P08684 2/20 0.41
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 2/20 0.39
APAF1 O14727 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 4/20 0.39
PARP1 P09874 3/20 0.39
LMNA P02545 2/20 0.39
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
PDPK1 O15530 1/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6932843 1.00 TSHR (0.41) TSHRCYP3A4ALDH1A1MEN1KMT2A
Fluoranthene SCHEMBL27664070 0.80 HSD17B10 (0.52) TSHRCYP3A4ALDH1A1MEN1KMT2A
Naphthalene SCHEMBL27319836 0.78 HTR2C (0.46) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL7604368 0.78 PARP1 (0.55) TSHRCYP3A4ALDH1A1MEN1KMT2A
Benzo[E]Pyrene SCHEMBL28296325 0.78 ALDH1A1 (0.53) TSHRCYP3A4ALDH1A1MEN1KMT2A
Indoline SCHEMBL29360339 0.75
Indoline SCHEMBL5629 0.75
SCHEMBL13828125 0.73 CYP3A4 (0.36) TSHRCYP3A4ALDH1A1KDM4EHSD17B10
Indoline SCHEMBL23295083 0.73 HTR2C (0.50) TSHRALDH1A1MEN1KMT2AKDM4E
Indoline SCHEMBL10723456 0.73 HTR2C (0.50) TSHRALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11279687-B2 Compounds and compositions for the inhibition of NAMPT VALO HEALTH, INC. (US) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11279687-B2 Compounds and compositions for the inhibition of NAMPT NAMPT, NNT, NQO1 TSHR 2779/4885CYP3A4 1074/4885ALDH1A1 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.